Template:Alpha 1-antitrypsin deficiency: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''Alph..." |
No edit summary |
||
Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency | [[Alpha 1-antitrypsin deficiency differential diagnosis|Differentiating Alpha 1-antitrypsin deficiency from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency | [[Alpha 1-antitrypsin deficiency epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency | [[Alpha 1-antitrypsin deficiency risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency | [[Alpha 1-antitrypsin deficiency screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency natural history|Natural History, Complications | [[Alpha 1-antitrypsin deficiency natural history|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 82: | Line 76: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency history and symptoms|History | [[Alpha 1-antitrypsin deficiency history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 94: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Alpha 1-antitrypsin deficiency laboratory tests| | [[Alpha 1-antitrypsin deficiency laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 180: | Line 174: | ||
[[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Type page name here case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " |
Revision as of 20:10, 26 August 2012
Alpha 1-antitrypsin deficiency Microchapters |
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Alpha 1-antitrypsin deficiency On the Web |
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency |
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency |